SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000909661-02-000002
Filing Date
2002-01-24
Accepted
2002-01-24 00:00:00
Documents
1
Group Members
ANDREW B. FREMDERDAVID I. COHENENRIQUE H. BOILINIFARALLON CAPITAL INSTITUTIONAL PARTNERS II, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS III, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS, L.P.FARALLON CAPITAL PARTNERS, L.PFARALLON PARTNERS, L.P.JOSEPH F. D

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D corr13d.txt SC 13D 123858
  Complete submission text file 0000909661-02-000002.txt   126452
Mailing Address
Business Address 256 E GRAND AVE STE 80 SOUTH SAN FRANCISCO CA 94080 4152446800
COR THERAPEUTICS INC / DE (Subject) CIK: 0000874865 (see all company filings)

IRS No.: 943060271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-41772 | Film No.: 02516585
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE MARITIME PLAZA SAN FRANCISCO CA 94111
Business Address ONE MARITIME PLAZA STE 11325 SAN FRANCISCO CA 94111 4154212132
FARALLON CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000909661 (see all company filings)

IRS No.: 943240279